Page last updated: 2024-10-29

2-propanol and Corneal Wavefront Aberration

2-propanol has been researched along with Corneal Wavefront Aberration in 9 studies

2-Propanol: An isomer of 1-PROPANOL. It is a colorless liquid having disinfectant properties. It is used in the manufacture of acetone and its derivatives and as a solvent. Topically, it is used as an antiseptic.
propan-2-ol : A secondary alcohol that is propane in which one of the hydrogens attached to the central carbon is substituted by a hydroxy group.

Corneal Wavefront Aberration: Asymmetries in the topography and refractive index of the corneal surface that affect visual acuity.

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (88.89)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Faramarzi, A1
Hassanpour, K1
Yazdani, S1
Moshirfar, M1
Narang, P2
Agarwal, A3
Ashok Kumar, D1
Holladay, J1
Jaganathasamy, N1
Kumar, DA1
Sivagnanam, S1
Wu, J1
Zhong, X1
Yang, B1
Wang, Z1
Yu, K1
Torii, H1
Negishi, K1
Watanabe, K1
Saiki, M1
Kato, N1
Tsubota, K1
Parsipour, F1
Razmju, H1
Khatavi, F1
Panahi, M1
Nouralishahi, A1
Peyman, A1
van Philips, LA1
Rudolph, M1
Laaser, K1
Bachmann, BO1
Cursiefen, C1
Epstein, D1
Kruse, FE1
Visser, N1
Bauer, NJ1
Nuijts, RM1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Descemet Endothelial Thickness Comparison Trial[NCT02373137]Phase 438 participants (Actual)Interventional2015-01-22Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Best Spectacle-Corrected Visual Acuity

The BSCVA was recorded at 4 meters by a masked refractionist certified for the study using a protocol adapted from the Age-Related Eye Disease Study using Early Treatment Diabetic Retinopathy Study charts: chart R(2110), chart 1(2111), and chart 2(2112) (Precision Vision, Woodstock, IL). (NCT02373137)
Timeframe: 24 Months

InterventionLogMar (Mean)
UT-DSAEK0.15
DMEK0.09

Best Spectacle-Corrected Visual Acuity

The BSCVA was recorded at 4 meters by a masked refractionist certified for the study using a protocol adapted from the Age-Related Eye Disease Study using Early Treatment Diabetic Retinopathy Study charts: chart R(2110), chart 1(2111), and chart 2(2112) (Precision Vision, Woodstock, IL). (NCT02373137)
Timeframe: 6 months

InterventionlogMAR (Mean)
UT-DSAEK0.22
DMEK0.05

Endothelial Cell Count

(NCT02373137)
Timeframe: 24 months

Interventioncells/mm^2 (Mean)
UT-DSAEK1626
DMEK1400

Adverse Events/Complication Rates

composite measure (NCT02373137)
Timeframe: 3, 6, 12, 24 months

,
Interventionnew adverse events reported (Number)
Adverse Events at 3 monthsAdverse Events at 6 monthsAdverse Events at 12 monthsAdverse Events at 24 months
DMEK6540
UT-DSAEK4410

Best Spectacle-Corrected Visual Acuity

The BSCVA was recorded at 4 meters by a masked refractionist certified for the study using a protocol adapted from the Age-Related Eye Disease Study using Early Treatment Diabetic Retinopathy Study charts: chart R(2110), chart 1(2111), and chart 2(2112) (Precision Vision, Woodstock, IL). (NCT02373137)
Timeframe: 3 and 12 months

,
InterventionlogMAR (Mean)
3 Months12 Months
DMEK0.110.04
UT-DSAEK0.240.16

Corneal Higher-Order Aberrations

As measured by Pentacam (NCT02373137)
Timeframe: 24 months

,
Interventionroot mean square in micrometers (Mean)
24 Months Anterior Cornea 4.0-mm24 Months Posterior Cornea 4.0-mm24 Months Anterior Cornea 6.0-mm24 Months Posterior Cornea 6.0-mm
DMEK0.2110.0860.6790.260
DSAEK0.2150.1550.7070.450

Corneal Higher-Order Aberrations

Corneal anterior and posterior surface higher-order aberrations (HOA) were measured with Scheimpflug imaging (Pentacam) before surgery and at 3, 6, and 12 months post-operatively. Zernike orders 3-8 were calculated at 4.0- and 6.0-mm-diameter optical zones. The results reported here represent total HOA (Sum of Zernike orders 3-8). Note a single observation was not available for one eye in the DMEK group at 6 months, this was analyzed with last observation carried forward. (NCT02373137)
Timeframe: 3, 6, 12 months

,
Interventionroot mean square in micrometers (Mean)
3 Months Anterior Cornea 4.0-mm3 Months Posterior Cornea 4.0-mm3 Months Anterior Cornea 6.0-mm3 Months Posterior Cornea 6.0-mm6 Months Anterior Cornea 4.0-mm6 Months Posterior Cornea 4.0-mm6 Months Anterior Cornea 6.0-mm6 Months Posterior Cornea 6.0-mm12 Months Anterior Cornea 4.0-mm12 Months Posterior Cornea 4.0-mm12 Months Anterior Cornea 6.0-mm12 Months Posterior Cornea 6.0-mm
DMEK0.2880.1160.8290.3460.2430.0950.7240.2880.2410.0980.7230.284
UT-DSAEK0.2740.2170.8970.6210.2300.1790.7390.5050.2280.1590.7250.459

Endothelial Cell Count

(NCT02373137)
Timeframe: 3, 6, 12 months

,
Interventioncells/mm^2 (Mean)
3 Months6 Months12 Months
DMEK203719631855
UT-DSAEK211421132070

Graft Failure/Graft Rejection

(NCT02373137)
Timeframe: Baseline 12 months

,
Interventioneyes (Count of Units)
Graft RejectionGraft Failure
DMEK01
UT-DSAEK01

Graft Thickness

As measured by Optical coherence tomography (OCT) and Pachymetry (NCT02373137)
Timeframe: 3, 6, 12, 24 months

,
Interventionroot mean square in micrometers (Mean)
3 months6 months12 months24 months
DMEK516.5519.67521.36526.88
UT-DSAEK589.36592.24585.96593.67

Interface Haze

As measured by Pentacam densitometry (NCT02373137)
Timeframe: 24 months

,
Interventioneyes (Number)
Mild Interface Haze at 24 monthsModerate Interface Haze at 24 monthsSevere Interface Haze at 24 months
DMEK000
UT-DSAEK010

Interface Haze

As measured by Pentacam densitometry (NCT02373137)
Timeframe: 3, 6, 12 months

,
Interventioneyes (Number)
Mild Interface Haze at 3 monthsModerate Interface Haze at 3 monthsSevere Interface Haze at 3 monthsMild Interface Haze at 6 monthsoderate Interface Haze at 6 monthsSevere Interface Haze at 6 monthsMild Interface Haze at 12 monthsoderate Interface Haze at 12 monthsSevere Interface Haze at 12 months
DMEK100100000
UT-DSAEK200210000

National Eye Institute - Visual Functioning Questionnaire (NEI-VFQ)

"The National Eye Institute has developed the validated Visual Functioning Questionnaire (NEI-VFQ) to assess the effect of ocular conditions and vision on patient quality of life. The answers to the questionnaire are transformed into sub-scales, including: general health, general vision, ocular pain, near activities, distance activities, social functioning, mental health, role difficulties, dependency, driving, color vision, peripheral vision. Participants are assigned a numerical value for each sub-scale based on their answers between 0-100, where higher numbers indicate better visual function. These sub-scales are then combined according to National Eye Institute guidelines into an overall composite score for each participant. This overall composite score is also on a scale of 0-100, where higher numbers indicate better visual function.~Composite score based on National Eye Institute guidelines." (NCT02373137)
Timeframe: Baseline, 12 months

,
InterventionComposite scores on a scale (Mean)
Baseline12 Months
DMEK72.387.3
UT-DSAEK72.585.9

Trials

1 trial available for 2-propanol and Corneal Wavefront Aberration

ArticleYear
Combined wavefront-guided laser in situ keratomileusis and aspheric ablation profile with iris registration to correct myopia.
    Journal of cataract and refractive surgery, 2013, Volume: 39, Issue:7

    Topics: Adolescent; Adult; Astigmatism; Contrast Sensitivity; Corneal Topography; Corneal Wavefront Aberrati

2013

Other Studies

8 other studies available for 2-propanol and Corneal Wavefront Aberration

ArticleYear
Lower- and higher-order aberrations after photorefractive keratectomy with and without compensation of pupil centroid shift: fellow eye comparison.
    Journal of cataract and refractive surgery, 2020, Volume: 46, Issue:2

    Topics: Adult; Astigmatism; Cornea; Corneal Wavefront Aberration; Female; Humans; Iris; Lasers, Excimer; Mal

2020
Pinhole pupilloplasty: Small-aperture optics for higher-order corneal aberrations.
    Journal of cataract and refractive surgery, 2019, Volume: 45, Issue:5

    Topics: Aged; Cornea; Corneal Topography; Corneal Wavefront Aberration; Humans; Iris; Light; Male; Middle Ag

2019
Application of Purkinje images for pinhole pupilloplasty and relevance to chord length mu.
    Journal of cataract and refractive surgery, 2019, Volume: 45, Issue:6

    Topics: Aged; Astigmatism; Corneal Wavefront Aberration; Female; Humans; Iris; Male; Middle Aged; Pseudophak

2019
Changes in higher-order aberrations after iris-fixated phakic intraocular lens implantation.
    Journal of refractive surgery (Thorofare, N.J. : 1995), 2013, Volume: 29, Issue:10

    Topics: Adult; Corneal Topography; Corneal Wavefront Aberration; Female; Humans; Iris; Lens Implantation, In

2013
Wavefront aberration and contrast sensitivity after implantation of foldable and rigid iris claw phakic intraocular lenses: Artiflex versus artisan.
    Indian journal of ophthalmology, 2016, Volume: 64, Issue:5

    Topics: Contrast Sensitivity; Corneal Wavefront Aberration; Follow-Up Studies; Humans; Hyperopia; Iris; Myop

2016
Higher-order aberrations after iris-fixated foldable phakic intraocular lens implantation and wavefront-guided photorefractive keratectomy for the correction of myopia.
    Journal of cataract and refractive surgery, 2011, Volume: 37, Issue:2

    Topics: Adult; Corneal Topography; Corneal Wavefront Aberration; Female; Humans; Iris; Lens Implantation, In

2011
Corneal higher-order aberrations after Descemet's membrane endothelial keratoplasty.
    Ophthalmology, 2012, Volume: 119, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Cornea; Corneal Wavefront Aberration; Descemet Stripping Endothelial

2012
Residual astigmatism following toric intraocular lens implantation related to pupil size.
    Journal of refractive surgery (Thorofare, N.J. : 1995), 2012, Volume: 28, Issue:10

    Topics: Aberrometry; Astigmatism; Corneal Topography; Corneal Wavefront Aberration; Female; Humans; Iris; Le

2012